Literature DB >> 15872291

Isothermal RNA sequence amplification method for rapid antituberculosis drug susceptibility testing of Mycobacterium tuberculosis.

Shunji Takakura1, Shigeo Tsuchiya, Naoko Fujihara, Toyoichiro Kudo, Yoshitsugu Iinuma, Satoshi Mitarai, Satoshi Ichiyama, Kiyoshi Yasukawa, Takahiko Ishiguro.   

Abstract

RNA transcript quantification by an isothermal sequence amplification reaction was evaluated for susceptibility testing of 15 Mycobacterium tuberculosis strains. Agreement with the proportion method on Ogawa egg medium and the BACTEC MGIT 960 system was 100 and 87% for rifampin, 93 and 100% for isoniazid, 60 and 53% for ethambutol, and 80 and 80% for streptomycin, respectively.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15872291      PMCID： PMC1153809          DOI： 10.1128/JCM.43.5.2489-2491.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors:  G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance.

Authors:  H Traore; K Fissette; I Bastian; M Devleeschouwer; F Portaels
Journal:  Int J Tuberc Lung Dis       Date:  2000-05       Impact factor: 2.373

3.  Intercalation activating fluorescence DNA probe and its application to homogeneous quantification of a target sequence by isothermal sequence amplification in a closed vessel.

Authors:  Takahiko Ishiguro; Juichi Saitoh; Ryuichi Horie; Toshinori Hayashi; Tetsuya Ishizuka; Shigeo Tsuchiya; Kiyoshi Yasukawa; Takahiro Kido; Yoshitsugu Nakaguchi; Mitsuaki Nishibuchi; Kunihiro Ueda
Journal:  Anal Biochem       Date:  2003-03-01       Impact factor: 3.365

4.  Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.

Authors:  B Yang; H Koga; H Ohno; K Ogawa; M Fukuda; Y Hirakata; S Maesaki; K Tomono; T Tashiro; S Kohno
Journal:  J Antimicrob Chemother       Date:  1998-11       Impact factor: 5.790

5.  Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City.

Authors:  R C Cooksey; G P Morlock; S Glickman; J T Crawford
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease.

Authors: 
Journal:  Int J Tuberc Lung Dis       Date:  1998-01       Impact factor: 2.373

7.  The resurgence of tuberculosis: is your laboratory ready?

Authors:  F C Tenover; J T Crawford; R E Huebner; L J Geiter; C R Horsburgh; R C Good
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.

Authors:  V Kapur; L L Li; S Iordanescu; M R Hamrick; A Wanger; B N Kreiswirth; J M Musser
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.

Authors:  D L Williams; L Spring; L Collins; L P Miller; L B Heifets; P R Gangadharam; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay.

Authors:  H De Beenhouwer; Z Lhiang; G Jannes; W Mijs; L Machtelinckx; R Rossau; H Traore; F Portaels
Journal:  Tuber Lung Dis       Date:  1995-10
View more
  3 in total

1.  Rapid detection of Mycobacterium tuberculosis in respiratory samples by transcription-reverse transcription concerted reaction with an automated system.

Authors:  Shunji Takakura; Shigeo Tsuchiya; Yuichi Isawa; Kiyoshi Yasukawa; Toshinori Hayashi; Motohisa Tomita; Katsuhiro Suzuki; Tatsuro Hasegawa; Takanori Tagami; Atsuyuki Kurashima; Satoshi Ichiyama
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Does the MGIT 960 system improve the turnaround times for growth detection and susceptibility testing of the Mycobacterium tuberculosis complex?

Authors:  Akos Somoskovi; Anne Clobridge; Susan C Larsen; Oleg Sinyavskiy; Suheyla Surucuoglu; Linda M Parsons; Max Salfinger
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  Integrated Amplification Microarrays for Infectious Disease Diagnostics.

Authors:  Darrell P Chandler; Lexi Bryant; Sara B Griesemer; Rui Gu; Christopher Knickerbocker; Alexander Kukhtin; Jennifer Parker; Cynthia Zimmerman; Kirsten St George; Christopher G Cooney
Journal:  Microarrays (Basel)       Date:  2012-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.